MAM
Starcom co Performics.Convonix bags Aditya Birla Health SEO mandate
MUMBAI: Continuing its successful account wins, Performics.Convonix has won the SEO duties on Aditya Birla Health Insurance. Performics.Convonix is the digital end- to- end solutions company under Starcom India.
Sarfaraz Khimani, Co-CEO, Performics.Convonix says, “This is a significant addition to our roster and we look forward to developing and implementing a cohesive strategy on Search for Aditya Birla Health Insurance. An area such as health insurance faces a shortage of clear, concise information. We hope to enhance brand visibility, website traffic and ultimately increase ROI significantly through SEO. SEO is an area which has a huge bearing on business deliverables and our data and insight-driven approach to SEO backed by our strong background in technology will go a long way in achieving both the client and our joint objectives.”
Aditya Birla Health Insurance Co Ltd. is a 51:49 joint venture between Aditya Birla Group and MMI Holdings. This partnership between a Fortune 500 Indian Group and one of South Africa’s largest insurance companies aims to revolutionise the Indian health insurance industry with a unique offering for customers.
Powered by a team of over 350 young and energetic digital marketing professionals Performics.Convonix is one of the foremost integrated digital marketing solutions provider in India. Starcom is a renowned media communications agency that architects connected human experiences to create value through precision marketing, content and technology solutions.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
